News

Emcor raised its full-year 2025 earnings per share guidance to a range of $24.50 to $25.75, exceeding estimates. It also ...
GE VernovaGEV is Monday's IBD Stock Of The Day, with the S&P 500 component trading in a buy zone in stock market action after ...
AbbVie ABBV has gained 22.5% so far this year against a decrease of 0.1% for the industry. The stock has also outperformed ...
Two doses of RZV were effective against HZ among adult patients aged 50 years and older with autoimmune diseases.